FDA committee will hear Perrigo's OTC bid for birth control med Opill in May

The FDA has identified a date for its long-awaited advisory committee meeting to discuss whether Perrigo’s birth control medication Opill can be used without a prescription.

The joint meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee has been set for May 9-10, Perrigo said in a release.